|
Market Closed -
Other stock markets
|
After hours 23:40:25 | |||
| 244.71 USD | +0.10% |
|
246.16 | +0.59% |
| 11-11 | ResMed Insider Sold Shares Worth $2,000,773, According to a Recent SEC Filing | MT |
| 11-05 | ResMed CFO Sells Shares | MT |
| Capitalization | 35.72B 30.8B 28.42B 27.12B 50.11B 3,165B 54.93B 338B 130B 1,511B 134B 131B 5,542B | P/E ratio 2026 * |
23.3x | P/E ratio 2027 * | 21x |
|---|---|---|---|---|---|
| Enterprise value | 34.49B 29.74B 27.44B 26.18B 48.38B 3,056B 53.03B 326B 126B 1,459B 129B 127B 5,351B | EV / Sales 2026 * |
6.16x | EV / Sales 2027 * | 5.59x |
| Free-Float |
76.64% | Yield 2026 * |
0.99% | Yield 2027 * | 1.09% |
Last Transcript: ResMed, Inc.
| 1 day | +0.59% | ||
| 1 week | -2.70% | ||
| Current month | -0.88% | ||
| 1 month | -9.37% | ||
| 3 months | -14.10% | ||
| 6 months | -2.77% | ||
| Current year | +7.01% |
| 1 week | 243.2 |  | 256 |
| 1 month | 239.41 | | 271.72 |
| Current year | 199.92 | | 293.81 |
| 1 year | 199.92 | | 293.81 |
| 3 years | 132.24 | | 293.81 |
| 5 years | 132.24 | | 301.34 |
| 10 years | 50.77 | | 301.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 52 | 28/02/2013 |
Brett Sandercock
DFI | Director of Finance/CFO | 58 | 31/12/2005 |
Jim Ellis
CMP | Compliance Officer | - | 31/12/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Rich Sulpizio
BRD | Director/Board Member | 75 | 24/08/2005 |
Ron Taylor
BRD | Director/Board Member | 77 | 31/12/2004 |
Mick Farrell
CHM | Chairman | 52 | 24/01/2023 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.09% | 26 M€ | +8.31% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.10% | -2.70% | +4.25% | +8.96% | 35.72B | |
| -2.00% | -0.92% | +10.54% | +5.81% | 213B | |
| -0.51% | -2.37% | +3.62% | +107.84% | 194B | |
| -0.35% | +5.00% | -4.36% | -17.18% | 156B | |
| -0.91% | +1.74% | +16.98% | +136.76% | 151B | |
| -1.18% | -4.84% | -16.36% | -19.57% | 53.88B | |
| -1.81% | +1.62% | +25.06% | +12.94% | 49.17B | |
| -1.57% | -1.51% | +13.73% | -1.77% | 40.97B | |
| -0.80% | +0.12% | -23.88% | -35.39% | 35.06B | |
| -3.44% | -3.31% | -13.61% | - | 32.17B | |
| Average | -1.32% | -1.29% | +1.60% | +22.05% | 96.04B | |
| Weighted average by Cap. | -1.33% | -1.02% | +4.81% | +41.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.6B 4.83B 4.46B 4.25B 7.86B 496B 8.61B 53B 20.43B 237B 21.01B 20.58B 869B | 6.02B 5.19B 4.79B 4.57B 8.44B 533B 9.26B 56.94B 21.95B 255B 22.58B 22.11B 934B |
| Net income | 1.54B 1.32B 1.22B 1.17B 2.15B 136B 2.36B 14.52B 5.6B 64.97B 5.76B 5.64B 238B | 1.71B 1.47B 1.36B 1.3B 2.39B 151B 2.62B 16.15B 6.22B 72.22B 6.4B 6.27B 265B |
| Net Debt | -1.23B -1.06B -979M -934M -1.73B -109B -1.89B -11.64B -4.49B -52.05B -4.61B -4.52B -191B | -2.1B -1.81B -1.67B -1.59B -2.94B -186B -3.23B -19.84B -7.65B -88.75B -7.87B -7.71B -325B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/11/25 | 244.71 $ | +0.10% | 1,037,918 |
| 14/11/25 | 244.46 $ | -3.03% | 1,008,371 |
| 13/11/25 | 252.11 $ | -0.30% | 1,124,347 |
| 12/11/25 | 252.86 $ | +0.17% | 1,270,218 |
| 11/11/25 | 252.43 $ | +0.93% | 1,316,781 |
Delayed Quote Nyse, November 17, 2025 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RMD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition